Effect of biologically occurring (poly) cationic compounds on some of the pancreatic activities.
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D002401:Cathepsin B; D002403:Cathepsins / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D009355:Neomycin / Q000494:pharmacology*; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D011700:Putrescine / Q000494:pharmacology*; D051381:Rats; D013095:Spermidine / Q000494:pharmacology*; D000516:alpha-Amylases / Q000378:metabolism
D007328:Insulin; D000135:Acid Phosphatase; D000516:alpha-Amylases; D002403:Cathepsins; D002401:Cathepsin B; D009355:Neomycin; D013095:Spermidine; D011700:Putrescine